Hensley Mark Earl (CIK 2065816) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-07). Recent activity: Buy HRTX (125,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-07 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Chief Operating Officer | Buy | 125,000 | $0 |
Source: SEC Form 4 filings · as of 2026-05-07